Characteristics | No. (n=126) | % | |
---|---|---|---|
Age | |||
70–74 | 53 | 42.1 | |
75–79 | 50 | 39.7 | |
>/=80 | 23 | 18.2 | |
Gender | |||
Male | 84 | 66.7 | |
Female | 42 | 33.3 | |
Disease | |||
Primary only | 65 | 51.6 | |
Local recurrence | 33 | 26.2 | |
Primary+Distant metastases | 28 | 22.2 | |
KPS Score | |||
≥90 | 44 | 34.9 | |
≥80–<90 | 70 | 55.6 | |
<80 | 12 | 9.5 | |
ECOG Score | |||
0 | 22 | 17.5 | |
1 | 78 | 61.9 | |
2–3 | 26 | 20.6 | |
Charlson Score | |||
0–1 | 41 | 32.6 | |
2–4 | 23 | 18.2 | |
5–8 | 62 | 49.2 | |
Comorbidities | |||
None | 72 | 57.1 | |
1 | 25 | 19.8 | |
2 | 22 | 17.5 | |
3–4 | 7 | 5.6 | |
Treatment purpose | |||
Curative Intent Treatment | 51 | 40.5 | |
Local control | 47 | 37.3 | |
Symptom control | 28 | 22.2 | |
Modality of RT | |||
RT only | 53 | 42.1 | |
CRT | 73 | 57.9 |